|
Post by kball on Aug 4, 2016 10:37:52 GMT -5
The last time I saw Dr. Combs, a little over a week ago, he had not heard a word from MNKD yet. They are hitting the doc's that were writing the scripts and stopped first I believe, so I'm hoping it will be soon! He has no issues with lung problems. Doesn't think there will be any and is excited about the product. So I'm crossing my fingers they get out there:-) Now even Drs that want to prescribe it can't move ahead. Pisses me off though i get that this is a company under a huge amount of stress and maybe not enough resources, money or time to handle it all
|
|
|
Post by therealisaching on Aug 4, 2016 10:40:28 GMT -5
Thanks for the update. Have to say its disappointing that Mike C hasnt reached out or had someone reach out to him since he said he was "on it". A captive audience of doc's who are interested in hearing about Afrezza seems like low hanging fruit.
|
|
|
Post by babaoriley on Aug 4, 2016 10:56:18 GMT -5
Thanks, Sports, keep us apprised, someone from MNKD should certainly be in touch with the doc NOW!
|
|
|
Post by saxcmann on Aug 4, 2016 11:01:51 GMT -5
The last time I saw Dr. Combs, a little over a week ago, he had not heard a word from MNKD yet. They are hitting the doc's that were writing the scripts and stopped first I believe, so I'm hoping it will be soon! He has no issues with lung problems. Doesn't think there will be any and is excited about the product. So I'm crossing my fingers they get out there:-) Now even Drs that want to prescribe it can't move ahead. Pisses me off though i get that this is a company under a huge amount of stress and maybe not enough resources, money or time to handle it all To confirm what sports said mnkd is targeting currently prescribing endos first. Dr Combs will probably be hit soon. Mnkd has already met with my endo friend and it was very positive. They will meet again in late August. He is prescribing 2-4 afrezza PTs per week. mnkd has also reached out for him to speak. So things are moving well. Hope my feedback helps Kball.
|
|
|
Post by tomson1355 on Aug 4, 2016 11:03:37 GMT -5
Well, even if it doesn't, it helps me. So, thank you.
|
|
|
Post by patten1962 on Aug 4, 2016 21:22:03 GMT -5
Imho, the thinking is, target Dr's that have used Afrezza in the past as Mike C and company fix any insurance and distribution problems. Don't want new Endos dealing with problems. August is the target for new users. I feel this is a very smart plan.
|
|
|
Post by dictatorsaurus on Aug 5, 2016 8:16:27 GMT -5
Scripts have dropped from the previous week.
We have a group of doctors interested in the drug yet MNKD hasn't reached out yet.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 5, 2016 9:35:32 GMT -5
Now even Drs that want to prescribe it can't move ahead. Pisses me off though i get that this is a company under a huge amount of stress and maybe not enough resources, money or time to handle it all To confirm what sports said mnkd is targeting currently prescribing endos first. Dr Combs will probably be hit soon. Mnkd has already met with my endo friend and it was very positive. They will meet again in late August. He is prescribing 2-4 afrezza PTs per week. mnkd has also reached out for him to speak. So things are moving well. Hope my feedback helps Kball. Agreed. Everyone chill. I have stated this before and some disagreed. Sales 101 is always go back to the well from previous buyers. Those are your easy patients to convert to sales. Not to mention those Dr's were willing to prescribe regardless of the label. Now you have the opportunity for easy sales and educate the Dr on the proper dosing
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 5, 2016 9:38:06 GMT -5
Scripts have dropped from the previous week. We have a group of doctors interested in the drug yet MNKD hasn't reached out yet. No offense to Sports but should Mike derail his strategy because a share holder messaged him on Twitter about a Dr she knows who may be willing to prescribe? Do you know what kind of messages these guys get from share holders and now all of a sudden they should take this one seriously? Come on guys this is rocket science lol
|
|
|
Post by careful2invest on Aug 5, 2016 10:01:20 GMT -5
Scripts have dropped from the previous week. We have a group of doctors interested in the drug yet MNKD hasn't reached out yet. That is very frustrating! I certainly was not expecting that. While I acknowledge that none of us on this mb know exactly what is going on behind the scenes (with the exception of Mike C) but Dr. Combs displayed enthusiasm around AFREZZA and to not tap that resource and the chain reaction of physician contacts to him that would follow, appears to be a missed opportunity. It makes one wonder how many others are out there that are interested in AFREZZA and are not being followed up with. We cannot afford to do this. I am tired of hearing peoples rationale of another negative event/result. We heard enough excuses while under Sanofi's control. (And even I tried to accept them at that time) But look where we ended up with them. I have owned this stock for almost eight years. A very grueling eight years. As we all know, this is a do or die launch! Every stone needs turned, every lead need a follow up, any opportunity for exposure of what AFREZZA can do for a Diabetic needs the full attention that it deserves! Come on fellas, complete Alfred Manns vision! Make AFREZZA a household name! As it is worthy. No more excuses, Lets see some results! Positive results! GLTA MNKD LONGS!
|
|
|
Post by dictatorsaurus on Aug 5, 2016 10:10:25 GMT -5
Scripts have dropped from the previous week. We have a group of doctors interested in the drug yet MNKD hasn't reached out yet. That is very frustrating! I certainly was not expecting that. While I acknowledge that none of us on this mb know exactly what is going on behind the scenes (with the exception of Mike C) but Dr. Combs displayed enthusiasm around AFREZZA and to not tap that resource and the chain reaction of physician contacts to him that would follow, appears to be a missed opportunity. It makes one wonder how many others are out there that are interested in AFREZZA and are not being followed up with. We cannot afford to do this. I am tired of hearing peoples rationale of another negative event/result. We heard enough excuses while under Sanofi's control. (And even I tried to accept them at that time) But look where we ended up with them. I have owned this stock for almost eight years. A very grueling eight years. As we all know, this is a do or die launch! Every stone needs turned, every lead need a follow up, any opportunity for exposure of what AFREZZA can do for a Diabetic needs the full attention that it deserves! Come on fellas, complete Alfred Manns vision! Make AFREZZA a household name! As it is worthy. No more excuses, Lets see some results! Positive results! GLTA MNKD LONGS! Some are perpetually positive that no matter what the numbers display, they remain blind to the facts. And one fact right now is the numbers are bad. I've heard to many excuses during the Sanofi era and the 2.0 era I really don't know where to start. Soft lauch, short week, extended holiday, Endos don't prescribe from Jan to Dec, cold weather, too much snow, too hot outside, local CVS had a power outage...etc. A few weeks might not represent an accurate trend. But it's still a trend. From the dozen or so diabetics that I know, none have heard anything from their endos about Afrezza. /End rant.
|
|
|
Post by obamayoumama on Aug 5, 2016 10:21:36 GMT -5
That is very frustrating! I certainly was not expecting that. While I acknowledge that none of us on this mb know exactly what is going on behind the scenes (with the exception of Mike C) but Dr. Combs displayed enthusiasm around AFREZZA and to not tap that resource and the chain reaction of physician contacts to him that would follow, appears to be a missed opportunity. It makes one wonder how many others are out there that are interested in AFREZZA and are not being followed up with. We cannot afford to do this. I am tired of hearing peoples rationale of another negative event/result. We heard enough excuses while under Sanofi's control. (And even I tried to accept them at that time) But look where we ended up with them. I have owned this stock for almost eight years. A very grueling eight years. As we all know, this is a do or die launch! Every stone needs turned, every lead need a follow up, any opportunity for exposure of what AFREZZA can do for a Diabetic needs the full attention that it deserves! Come on fellas, complete Alfred Manns vision! Make AFREZZA a household name! As it is worthy. No more excuses, Lets see some results! Positive results! GLTA MNKD LONGS! Some are perpetually positive that no matter what the numbers display, they remain blind to the facts. And one fact right now is the numbers are bad. I've heard to many excuses during the Sanofi era and the 2.0 era I really don't know where to start. Soft lauch, short week, extended holiday, Endos don't prescribe from Jan to Dec, cold weather, too much snow, too hot outside, local CVS had a power outage...etc. A few weeks might not represent an accurate trend. But it's still a trend. From the dozen or so diabetics that I know, none have heard anything from their endos about Afrezza. /End rant. People you need to be realistic. This was the first week's results with MNKD Afrezza. Doctors need to be educated, sample packs need to be distributed, patients need prior authorization to be completed and then you will get NRXs up.
|
|
|
Post by tomson1355 on Aug 5, 2016 10:33:57 GMT -5
The conference this thread is about is not yet a missed opportunity. It will be a missed opportunity if the conference comes and goes without participation by MNKD. Until then, I'm expecting that management will get on it. It's not too late.
|
|
|
Post by cjc04 on Aug 5, 2016 10:45:47 GMT -5
Scripts have dropped from the previous week. We have a group of doctors interested in the drug yet MNKD hasn't reached out yet. No offense to Sports but should Mike derail his strategy because a share holder messaged him on Twitter about a Dr she knows who may be willing to prescribe? Do you know what kind of messages these guys get from share holders and now all of a sudden they should take this one seriously? Come on guys this is rocket science lol I agree, it would look desperate and like they're scrambling for leads. I also agree with you on spending time with all the currently prescribing docs & endos first, not just for the sake of sales, but more importantly to get them on board with the new message/system straight from MNKD. Here's something a little positive for everyone...... So my wife gets her script filled a couple weeks ago. When she gets it home this past Friday, she realizes they made a mistake in filling the script and she only got 1/2 of what she needed for the 3 months. She calls the pharmacy & her endo and they start working on it. She then gets a call from the pharmisist on SATURDAY telling her it's straightened out and the rest will be there MONDAY..... About 30 mins later, he calls her again just to let her know that the product coming in on Monday is from a different company but not to worry it's the same thing...... Sure enough, on Monday afternoon she picks up her MANNKIND Afrezza!!!! Saturday to Monday, not too shabby!!
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 5, 2016 11:00:52 GMT -5
Scripts have dropped from the previous week. We have a group of doctors interested in the drug yet MNKD hasn't reached out yet. That is very frustrating! I certainly was not expecting that. While I acknowledge that none of us on this mb know exactly what is going on behind the scenes (with the exception of Mike C) but Dr. Combs displayed enthusiasm around AFREZZA and to not tap that resource and the chain reaction of physician contacts to him that would follow, appears to be a missed opportunity. It makes one wonder how many others are out there that are interested in AFREZZA and are not being followed up with. We cannot afford to do this. I am tired of hearing peoples rationale of another negative event/result. We heard enough excuses while under Sanofi's control. (And even I tried to accept them at that time) But look where we ended up with them. I have owned this stock for almost eight years. A very grueling eight years. As we all know, this is a do or die launch! Every stone needs turned, every lead need a follow up, any opportunity for exposure of what AFREZZA can do for a Diabetic needs the full attention that it deserves! Come on fellas, complete Alfred Manns vision! Make AFREZZA a household name! As it is worthy. No more excuses, Lets see some results! Positive results! GLTA MNKD LONGS! did you write to mannkind either to Matt or Mike? posting here wouldnt get far
|
|